mcla-128
Showing 1 - 3 of 3
Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)
Active, not recruiting
- Breast Cancer Metastatic
- MCLA-128
- +3 more
-
Los Angeles, California
- +24 more
Aug 10, 2022
NSCLC Harboring NRG1 Fusion, Metastatic Castration-resistant Prostate Cancer Trial in Whittier, Lake Mary (Afatinib Oral Tablet,
Recruiting
- NSCLC Harboring NRG1 Fusion
- Metastatic Castration-resistant Prostate Cancer
- Afatinib Oral Tablet
- +3 more
-
Whittier, California
- +1 more
Dec 20, 2022
NRG1, NRG1 Fusion, Pancreatic Cancer Trial (MCLA-128)
Available
- NRG1
- +11 more
- MCLA-128
- (no location specified)
Jul 21, 2021